◆英語タイトル:NovoCure Ltd (NVCR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011408
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月22日
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellular carcinoma, breast cancer and small cell lung cancer, among others. It also offers products for other indications such as glioblastoma and diagnosed glioblastoma. Novocure operates along with its subsidiaries located in New Hampshire, the US; and Berlin, Germany. The company owns and operates a research centre in Haifa, Israel. It also has presence in Japan and Switzerland. NovoCure is headquartered in Jersey, the UK.
NovoCure Ltd (NVCR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NovoCure Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
NovoCure Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
NovoCure Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
NovoCure Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
NovoCure Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
NovoCure Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
NovoCure Secures USD25 Million from Pharmakon 10
Equity Offering 11
NovoCure Announces Partial Exercise of Underwriter’s Option for IPO for USD173.3 Million 11
NovoCure Raises USD95 Million in Public Offering of Series J Shares 13
NovoCure Raises USD194 Million in Public Offering of Series I Shares 14
NovoCure Raises USD55 Million in Public Offering of Series H Shares 15
NovoCure Raises USD44.1 Million in Public Offering of Shares 16
NovoCure Ltd – Key Competitors 17
NovoCure Ltd – Key Employees 18
NovoCure Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Oct 26, 2017: Novocure Reports Third Quarter 2017 Financial Results and Provides Company Update 20
Jul 27, 2017: Novocure Reports Second Quarter 2017 Financial Results and Provides Company Update 23
Apr 27, 2017: Novocure Reports First Quarter 2017 Financial Results and Provides Company Update 26
Nov 02, 2016: Novocure Reports Third Quarter 2016 Financial Results and Provides Company Update 28
Jul 28, 2016: Novocure Reports Second Quarter 2016 Financial Results and Provides Company Update 31
Corporate Communications 34
May 11, 2017: Martin J. Madden Joins Novocure Board of Directors 34
May 11, 2016: Novocure Enters into Employment Agreement with William Doyle 35
Product News 36
Nov 08, 2017: Novocure Announces 13 Preclinical Presentations Highlighting Data on Tumor Treating Fields’ Mechanism of Action at 22nd Annual Meeting of the Society for Neuro-Oncology 36
Sep 06, 2017: Novocure Announces Data Presentations at the ESMO 2017 Congress 38
Jul 11, 2017: Data on Delivery of Tumor Treating Fields to be Presented at the 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society 39
Dec 08, 2016: Novocure Announces Agenda for Research and Development Day on Dec. 12, 2016 40
Jul 28, 2016: Novocure to Host Research and Development Day on Dec. 12, 2016 41
03/09/2016: Red Journal Publishes Data Supporting Personalized Treatment Planning to Increase TTFields Efficacy for Patients with Glioblastoma 42
03/03/2016: Humana Issues Positive Coverage Decision For Optune 43
02/12/2016: Anthem Issues Positive Coverage Decision For Optune in Newly Diagnosed Glioblastoma 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45
List of Tables
NovoCure Ltd, Medical Equipment, Key Facts, 2016 2
NovoCure Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
NovoCure Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
NovoCure Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
NovoCure Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
NovoCure Ltd, Deals By Market, 2011 to YTD 2017 8
NovoCure Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
NovoCure Secures USD25 Million from Pharmakon 10
NovoCure Announces Partial Exercise of Underwriter’s Option for IPO for USD173.3 Million 11
NovoCure Raises USD95 Million in Public Offering of Series J Shares 13
NovoCure Raises USD194 Million in Public Offering of Series I Shares 14
NovoCure Raises USD55 Million in Public Offering of Series H Shares 15
NovoCure Raises USD44.1 Million in Public Offering of Shares 16
NovoCure Ltd, Key Competitors 17
NovoCure Ltd, Key Employees 18
NovoCure Ltd, Other Locations 19
NovoCure Ltd, Subsidiaries 19